Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Sino Biopharmaceutical Limited    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
My previous session
Most popular
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
02/18/2019 02/19/2019 02/20/2019 02/21/2019 02/22/2019 Date
6.96 6.54 6.41 6.52 6.58 Last
65431184 107019035 110559682 58156500 46851591 Volume
+1.02% -6.03% -1.99% +1.72% +0.92% Change
Financials (CNY)
Sales 2018 20 653 M
EBIT 2018 5 474 M
Net income 2018 2 882 M
Finance 2018 3 148 M
Yield 2018 0,90%
Sales 2019 23 587 M
EBIT 2019 6 182 M
Net income 2019 3 327 M
Finance 2019 6 527 M
Yield 2019 1,03%
P/E ratio 2018 24,17
P/E ratio 2019 21,23
EV / Sales2018 3,28x
EV / Sales2019 2,73x
Capitalization 70 929 M
More Financials
Company
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicines and Chemical Medicines segment is engaged in the manufacture, sales and distribution of... 
Sector
Pharmaceuticals
Calendar
03/27Earnings Release
More about the company
Surperformance© ratings of Sino Biopharmaceutical Lim
Trading Rating : Investor Rating :
More Ratings
Latest news on SINO BIOPHARMACEUTICAL LIM
02/11ASIA MARKETS: Asian Markets Gain As Investors Pin Hopes On U.S.-China Trade T..
DJ
01/18SINO BIOPHARMACEUTICAL : Biopharma gets anti-tumour drug approval
AQ
01/10SINO BIOPHARMACEUTICAL : Biopharma get approval for linezolid injection
AQ
01/09ASIA MARKETS: Asian Markets Mixed As China Inflation Data Offsets Trade-talk ..
DJ
2018SINO BIOPHARMACEUTICAL : gets painkiller approval
AQ
2018SINO BIOPHARMACEUTICAL : Biopharm & director buy back company shares
AQ
2018SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for interim dividend
FA
2018SINO BIOPHARMACEUTICAL : Announces 2018 Third Quarterly Results
AQ
2018SINO BIOPHARMACEUTICAL LIMITED : quaterly earnings release
2018ASIA MARKETS: Asian Stock Markets Recover, Led By Japan And Hong Kong
DJ
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIM
More recommendations
Sector news : Pharmaceuticals - NEC
02/23SPARK THERAPEUTICS : Roche nearing $5 billion deal to acquire Spark Therapeutics..
RE
02/23Roche Nears Deal to Buy Spark Therapeutics for Close to $5 Billion
DJ
02/22U.K. Closes Corruption Probes of GlaxoSmithKline, Rolls-Royce Individuals
DJ
02/22ALEXION PHARMACEUTICALS : Pharma Says FDA Gives Priority Review and Accepts sBLA..
DJ
02/22U.K.'s Fraud Agency Won't Prosecute Individuals in Rolls-Royce Corruption Cas..
DJ
More sector news : Pharmaceuticals - NEC
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO BIOPHARMACEUTICAL LIM
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 7,58  CNY
Spread / Average Target 35%
EPS Revisions
Managers
NameTitle
Ping Tse Chief Executive Officer & Executive Director
Y Y Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Hsin Tse Executive Director & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
SINO BIOPHARMACEUTICAL LIMITED27.27%10 569
JOHNSON & JOHNSON5.85%363 785
PFIZER-3.46%249 168
ROCHE HOLDING LTD.13.89%238 335
NOVARTIS8.12%231 565
MERCK AND COMPANY5.71%210 032